IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis

Files

IL17IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.pdf (3.5 MB)

Date

2018

Type:

Article

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

41

Vistas totales

0
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

https://doi.org/10.3389/fimmu.2018.00802
 http://hdl.handle.net/11447/4578

item.page.extent

item.page.accessRights

item.page.other

item.page.references

Abstract

The therapeutic effect of mesenchymal stem cells (MSCs) in multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) model has been well described. This effect is, in part, med...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Frontiers in Immunology; 2018; 9:802

Keywords

Cellular therapy , Experimental autoimmune encephalomyelitis , Mesenchymal stem cells , IL17 , IL17RA

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026

Implementado por OpenGeek Services